ArticleDiagnostics (Basel, Switzerland)2021

uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study.

Marie Øbro Fosbøl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.